LLY SEC filings (2026)
CIK 59478 · Pharmaceutical Preparations (SIC 2834) · incorporated in IN · fiscal year ends in December
3,915 filings on EDGAR since 1994 · 34 annual, 101 quarterly, 242 current · financial statements · earnings
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by what they covered, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
August 2026
- Aug 17Insider saleJonsson Patrik (EVP & President, LLY Int'l) sold 6,500 shares for $7.6M at $1,175.10 under a 10b5-1 plan
- Aug 10Insider saleZakrowski Donald A (SVP, Finance, & CAO) sold 2,000 shares for $2.4M at $1,185.01 under a 10b5-1 plan
- Aug 7Insider saleHakim Anat (EVP, GC & Secretary) sold 5,000 shares for $6.0M at $1,190.00 under a 10b5-1 plan
- Aug 5EarningsEarnings release — EPS $8.38 vs $6.01 est. (+39.4%); revenue $22.97B (+48% y/y) 4.9%
- Aug 5ReportQuarterly report, Q2 2026 — revenue $22.97B (+48% y/y), net income $7.09B, EPS $7.94
June 2026
May 2026
- May 208-K8-K · Other events
- May 78-K8-K · Shareholder vote results
- May 6Insider saleLILLY ENDOWMENT INC (Former 10% Shareholder) sold 15,828 shares for $15.8M at $995.23–$996.18
April 2026
- Apr 30EarningsEarnings release — EPS $8.55 vs $7.06 est. (+21.1%); revenue $19.80B (+56% y/y) 9.8%
- Apr 30ReportQuarterly report, Q1 2026 — revenue $19.80B (+56% y/y), net income $7.40B, EPS $8.26
- Apr 29ProxyProxy · Shareholder exempt solicitation
March 2026
- Mar 31ProxyProxy · Proxy statements
- Mar 20ProxyProxy · Additional proxy materials
- Mar 20ProxyProxy · Proxy statement
- Mar 6ProxyProxy · Preliminary proxy statement
February 2026
January 2026
November 2025
- Nov 218-K8-K · Directors or officers; compensation
October 2025
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $358.5M in 7 sales and bought nothing on the open market; 97 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| Aug 17, 2026Form 4 | Jonsson PatrikEVP & President, LLY Int'lSold · $7.6M · 6,500 sh · 10b5-1 |
| Aug 10, 2026Form 4 | Zakrowski Donald ASVP, Finance, & CAOSold · $2.4M · 2,000 sh · 10b5-1 |
| Aug 7, 2026Form 4 | Hakim AnatEVP, GC & SecretarySold · $6.0M · 5,000 sh · 10b5-1 |
| Jun 10, 2026Form 4 | Yuffa IlyaEVP&Pres, LLY USA&Global CapabSold · $2.9M · 2,500 sh · 10b5-1 |
| May 6, 2026Form 4 | LILLY ENDOWMENT INCFormer 10% ShareholderSold · $15.8M · 15,828 sh |
| Jan 7, 2026Form 4 | LILLY ENDOWMENT INC10% ownerSold · $322.4M · 292,148 sh |
| Jan 5, 2026Form 4 | LILLY ENDOWMENT INC10% ownerSold · $1.5M · 1,390 sh |
Awards, exercises, withholding and plan purchases · 97 transactions
| Date | Insider |
|---|---|
| Sep 21, 2026Form 4 | LUCIANO JUAN RDirectorAward · $16K · 13.664 sh |
| Sep 21, 2026Form 4 | Alvarez RalphDirectorAward · $12K · 10.659 sh |
| Sep 21, 2026Form 4 | Fyrwald J ErikDirectorAward · $9,917 · 8.513 sh |
| Sep 21, 2026Form 4 | Sulzberger GabrielleDirectorAward · $4,958 · 4.257 sh |
| Sep 9, 2026Form 4 | Seymour MelissaEVP, Global QualityGift · $0 · 12 sh |
| Sep 2, 2026Form 4 | Dozier EricEVP, Chief People OfficerGift · $0 · 216 sh |
| Sep 2, 2026Form 4 | Hernandez EdgardoEVP & Pres., Mfg. OperationsGift · $0 · 13 sh |
| Aug 17, 2026Form 4 | LUCIANO JUAN RDirectorAward · $16K · 13.453 sh |
| Aug 17, 2026Form 4 | Alvarez RalphDirectorAward · $12K · 10.495 sh |
| Aug 17, 2026Form 4 | Fyrwald J ErikDirectorAward · $9,917 · 8.382 sh |
| Aug 17, 2026Form 4 | Sulzberger GabrielleDirectorAward · $4,958 · 4.191 sh |
| Aug 1, 2026Form 4 | Seymour MelissaEVP, Global QualityTax withholding · $504K · 438.707 sh |
| Aug 1, 2026Form 4 | Seymour MelissaEVP, Global QualityExercise or conversion · $0 · 981 sh |
| Aug 1, 2026Form 4 | Seymour MelissaEVP, Global QualityExercise or conversion · Restricted Stock Unit · $0 · 981 sh |
| Jul 20, 2026Form 4 | LUCIANO JUAN RDirectorAward · $16K · 13.878 sh |
| Jul 20, 2026Form 4 | Alvarez RalphDirectorAward · $12K · 10.826 sh |
| Jul 20, 2026Form 4 | Fyrwald J ErikDirectorAward · $9,917 · 8.647 sh |
| Jul 20, 2026Form 4 | Sulzberger GabrielleDirectorAward · $4,958 · 4.323 sh |
| Jun 15, 2026Form 4 | LUCIANO JUAN RDirectorAward · $16K · 14.094 sh |
| Jun 15, 2026Form 4 | Alvarez RalphDirectorAward · $12K · 10.995 sh |
| Jun 15, 2026Form 4 | Fyrwald J ErikDirectorAward · $9,917 · 8.781 sh |
| Jun 15, 2026Form 4 | Sulzberger GabrielleDirectorAward · $4,958 · 4.39 sh |
| May 18, 2026Form 4 | LUCIANO JUAN RDirectorAward · $16K · 16.109 sh |
| May 18, 2026Form 4 | Alvarez RalphDirectorAward · $12K · 12.566 sh |
| May 18, 2026Form 4 | Fyrwald J ErikDirectorAward · $9,916 · 10.036 sh |
| May 18, 2026Form 4 | Sulzberger GabrielleDirectorAward · $4,958 · 5.018 sh |
| Apr 20, 2026Form 4 | LUCIANO JUAN RDirectorAward · $16K · 17.303 sh |
| Apr 20, 2026Form 4 | Alvarez RalphDirectorAward · $12K · 13.498 sh |
| Apr 20, 2026Form 4 | Fyrwald J ErikDirectorAward · $9,917 · 10.78 sh |
| Apr 20, 2026Form 4 | Sulzberger GabrielleDirectorAward · $4,958 · 5.39 sh |
| Mar 16, 2026Form 4 | LUCIANO JUAN RDirectorAward · $16K · 16.092 sh |
| Mar 16, 2026Form 4 | Alvarez RalphDirectorAward · $12K · 12.553 sh |
| Mar 16, 2026Form 4 | Fyrwald J ErikDirectorAward · $9,917 · 10.026 sh |
| Mar 16, 2026Form 4 | Sulzberger GabrielleDirectorAward · $4,958 · 5.013 sh |
| Feb 19, 2026Form 4 | Dozier EricEVP, Chief People OfficerGift · $0 · 481 sh |
| Feb 17, 2026Form 4 | LUCIANO JUAN RDirectorAward · $16K · 15.363 sh |
| Feb 17, 2026Form 4 | Alvarez RalphDirectorAward · $12K · 11.985 sh |
| Feb 17, 2026Form 4 | Fyrwald J ErikDirectorAward · $9,917 · 9.572 sh |
| Feb 17, 2026Form 4 | Sulzberger GabrielleDirectorAward · $4,959 · 4.786 sh |
| Feb 16, 2026Form 4 | Brown Adrienne SEVP, President LLY ImmTax withholding · $177K · 169.966 sh |
| Feb 16, 2026Form 4 | Montarce LucasEVP & CFOTax withholding · $166K · 159.733 sh |
| Feb 16, 2026Form 4 | Custer Kenneth L.EVP & President, Card Met HlthTax withholding · $95K · 91.311 sh |
| Feb 16, 2026Form 4 | Zakrowski Donald ASVP, Finance, & CAOTax withholding · $85K · 81.553 sh |
| Feb 16, 2026Form 4 | Brown Adrienne SEVP, President LLY ImmExercise or conversion · $0 · 391 sh |
| Feb 16, 2026Form 4 | Brown Adrienne SEVP, President LLY ImmExercise or conversion · Restricted Stock Unit · $0 · 391 sh |
| Feb 16, 2026Form 4 | Montarce LucasEVP & CFOExercise or conversion · $0 · 368 sh |
| Feb 16, 2026Form 4 | Montarce LucasEVP & CFOExercise or conversion · Restricted Stock Unit · $0 · 368 sh |
| Feb 16, 2026Form 4 | Custer Kenneth L.EVP & President, Card Met HlthExercise or conversion · $0 · 207 sh |
| Feb 16, 2026Form 4 | Custer Kenneth L.EVP & President, Card Met HlthExercise or conversion · Restricted Stock Unit · $0 · 207 sh |
| Feb 16, 2026Form 4 | Zakrowski Donald ASVP, Finance, & CAOExercise or conversion · $0 · 184 sh |
| Feb 16, 2026Form 4 | Zakrowski Donald ASVP, Finance, & CAOExercise or conversion · Restricted Stock Unit · $0 · 184 sh |
| Feb 9, 2026Form 4 | Ricks David APresident, Chair, and CEO · DirectorAward · $40.7M · 38,913.584 sh |
| Feb 9, 2026Form 4 | Skovronsky DanielEVP, CS&PO & Pres. LRLAward · $16.2M · 15,547.862 sh |
| Feb 9, 2026Form 4 ×2 | Rau DiogoEVP & CIDOAward · $9.4M · 9,031.484 sh |
| Feb 9, 2026Form 4 | Hakim AnatEVP, GC & SecretaryAward · $8.6M · 8,277.919 sh |
| Feb 9, 2026Form 4 | Van Naarden JacobEVP,Pres LLY Oncology&HdCorpBDAward · $5.1M · 4,865.888 sh |
| Feb 9, 2026Form 4 | Jonsson PatrikEVP & President, LLY Int'lAward · $5.0M · 4,818.052 sh |
| Feb 9, 2026Form 4 | Hernandez EdgardoEVP & Pres., Mfg. OperationsAward · $4.6M · 4,383.734 sh |
| Feb 9, 2026Form 4 | Yuffa IlyaEVP&Pres, LLY USA&Global CapabAward · $4.3M · 4,162.504 sh |
| Feb 9, 2026Form 4 | Dozier EricEVP, Chief People OfficerAward · $3.7M · 3,512.294 sh |
| Feb 9, 2026Form 4 | Montarce LucasEVP & CFOAward · $1.4M · 1,365.47 sh |
| Feb 9, 2026Form 4 | Brown Adrienne SEVP, President LLY ImmAward · $1.2M · 1,196.308 sh |
| Feb 9, 2026Form 4 | Custer Kenneth L.EVP & President, Card Met HlthAward · $689K · 659.28 sh |
| Feb 9, 2026Form 4 | Zakrowski Donald ASVP, Finance, & CAOAward · $610K · 583.784 sh |
| Feb 9, 2026Form 4 | Zakrowski Donald ASVP, Finance, & CAOAward · Restricted Stock Unit · $0 · 199.472 sh |
| Feb 1, 2026Form 4 | Ricks David APresident, Chair, and CEO · DirectorTax withholding · $14.8M · 14,296.654 sh |
| Feb 1, 2026Form 4 | Skovronsky DanielEVP, CS&PO & Pres. LRLTax withholding · $5.9M · 5,641.249 sh |
| Feb 1, 2026Form 4 | Hakim AnatEVP, GC & SecretaryTax withholding · $3.1M · 2,953.395 sh |
| Feb 1, 2026Form 4 | Van Naarden JacobEVP,Pres LLY Oncology&HdCorpBDTax withholding · $2.0M · 1,909.375 sh |
| Feb 1, 2026Form 4 | Jonsson PatrikEVP & President, LLY Int'lTax withholding · $1.8M · 1,752.071 sh |
| Feb 1, 2026Form 4 | Rau DiogoEVP & CIDOTax withholding · $1.7M · 1,673.538 sh |
| Feb 1, 2026Form 4 | Hernandez EdgardoEVP & Pres., Mfg. OperationsTax withholding · $1.7M · 1,591.452 sh |
| Feb 1, 2026Form 4 | Yuffa IlyaEVP&Pres, LLY USA&Global CapabTax withholding · $1.6M · 1,512.364 sh |
| Feb 1, 2026Form 4 | Dozier EricEVP, Chief People OfficerTax withholding · $1.3M · 1,272.992 sh |
| Feb 1, 2026Form 4 | Ricks David APresident, Chair, and CEO · DirectorExercise or conversion · $0 · 31,932 sh |
| Feb 1, 2026Form 4 | Ricks David APresident, Chair, and CEO · DirectorExercise or conversion · Restricted Stock Unit · $0 · 31,932 sh |
| Feb 1, 2026Form 4 | Skovronsky DanielEVP, CS&PO & Pres. LRLExercise or conversion · $0 · 12,684 sh |
| Feb 1, 2026Form 4 | Skovronsky DanielEVP, CS&PO & Pres. LRLExercise or conversion · Restricted Stock Unit · $0 · 12,684 sh |
| Feb 1, 2026Form 4 | Hakim AnatEVP, GC & SecretaryExercise or conversion · $0 · 6,700 sh |
| Feb 1, 2026Form 4 | Hakim AnatEVP, GC & SecretaryExercise or conversion · Restricted Stock Unit · $0 · 6,700 sh |
| Feb 1, 2026Form 4 | Van Naarden JacobEVP,Pres LLY Oncology&HdCorpBDExercise or conversion · $0 · 4,108 sh |
| Feb 1, 2026Form 4 | Van Naarden JacobEVP,Pres LLY Oncology&HdCorpBDExercise or conversion · Restricted Stock Unit · $0 · 4,108 sh |
| Feb 1, 2026Form 4 | Jonsson PatrikEVP & President, LLY Int'lExercise or conversion · $0 · 3,930 sh |
| Feb 1, 2026Form 4 | Jonsson PatrikEVP & President, LLY Int'lExercise or conversion · Restricted Stock Unit · $0 · 3,930 sh |
| Feb 1, 2026Form 4 | Rau DiogoEVP & CIDOExercise or conversion · $0 · 3,752 sh |
| Feb 1, 2026Form 4 | Rau DiogoEVP & CIDOExercise or conversion · Restricted Stock Unit · $0 · 3,752 sh |
| Feb 1, 2026Form 4 | Hernandez EdgardoEVP & Pres., Mfg. OperationsExercise or conversion · $0 · 3,572 sh |
| Feb 1, 2026Form 4 | Hernandez EdgardoEVP & Pres., Mfg. OperationsExercise or conversion · Restricted Stock Unit · $0 · 3,572 sh |
| Feb 1, 2026Form 4 | Yuffa IlyaEVP&Pres, LLY USA&Global CapabExercise or conversion · $0 · 3,394 sh |
| Feb 1, 2026Form 4 | Yuffa IlyaEVP&Pres, LLY USA&Global CapabExercise or conversion · Restricted Stock Unit · $0 · 3,394 sh |
| Feb 1, 2026Form 4 | Dozier EricEVP, Chief People OfficerExercise or conversion · $0 · 2,858 sh |
| Feb 1, 2026Form 4 | Dozier EricEVP, Chief People OfficerExercise or conversion · Restricted Stock Unit · $0 · 2,858 sh |
| Jan 20, 2026Form 4 | LUCIANO JUAN RDirectorAward · $16K · 15.286 sh |
| Jan 20, 2026Form 4 | Alvarez RalphDirectorAward · $12K · 11.924 sh |
| Jan 20, 2026Form 4 | Fyrwald J ErikDirectorAward · $9,916 · 9.523 sh |
| Jan 20, 2026Form 4 | Sulzberger GabrielleDirectorAward · $4,959 · 4.762 sh |
| Sep 22, 2025Form 4 | Seymour MelissaEVP, Global QualityGift · $0 · 17 sh |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K is described by its items. A form opens the document on EDGAR, or the filing’s index where it furnishes exhibits (an earnings release is the 8-K’s Exhibit 99.1).
2026 · 13 filings
| Filed | What it is |
|---|---|
| Aug 5, 202610-Q | Quarterly report, Q2 2026 — revenue $22.97B (+48% y/y), net income $7.09B, EPS $7.94 |
| Aug 5, 20268-K | Earnings release — EPS $8.38 vs $6.01 est. (+39.4%); revenue $22.97B (+48% y/y) 4.9% |
| May 20, 20268-K | Other events |
| May 7, 20268-K | Shareholder vote results |
| Apr 30, 202610-Q | Quarterly report, Q1 2026 — revenue $19.80B (+56% y/y), net income $7.40B, EPS $8.26 |
| Apr 30, 20268-K | Earnings release — EPS $8.55 vs $7.06 est. (+21.1%); revenue $19.80B (+56% y/y) 9.8% |
| Apr 29, 2026PX14A6G | Shareholder exempt solicitation |
| Mar 31, 2026DFAN14A | Proxy statements |
| Mar 20, 2026DEFA14A | Additional proxy materials |
| Mar 20, 2026DEF 14A | Proxy statement |
| Mar 6, 2026PRE 14A | Preliminary proxy statement |
| Feb 12, 202610-K | Annual report, FY2025 — revenue $65.18B (+45% y/y), net income $20.64B, EPS $22.95 |
| Feb 4, 20268-K | Earnings release — EPS $7.54 vs $6.99 est. (+7.9%); revenue $19.29B (+43% y/y) 10.3% |
2025 · 17 filings
| Filed | What it is |
|---|---|
| Nov 21, 20258-K | Directors or officers; compensation |
| Oct 30, 202510-Q | Quarterly report, Q3 2025 — revenue $17.60B (+54% y/y), net income $5.58B, EPS $6.21 |
| Oct 30, 20258-K | Earnings release — EPS $7.02 vs $6.02 est. (+16.6%); revenue $17.60B (+54% y/y) 3.8% |
| Aug 20, 20258-K | Other events |
| Aug 7, 202510-Q | Quarterly report, Q2 2025 — revenue $15.56B (+38% y/y), net income $5.66B, EPS $6.29 |
| Aug 7, 20258-K | Results of operations |
| May 8, 20258-K | Shareholder vote results |
| May 1, 202510-Q | Quarterly report, Q1 2025 — revenue $12.73B (+45% y/y), net income $2.76B, EPS $3.06 |
| May 1, 20258-K | Results of operations |
| Mar 31, 2025PX14A6G | Shareholder exempt solicitation |
| Mar 21, 2025DEFA14A | Additional proxy materials |
| Mar 21, 2025DEF 14A | Proxy statement |
| Mar 7, 2025PRE 14A | Preliminary proxy statement |
| Feb 19, 202510-K | Annual report, FY2024 — revenue $45.04B (+32% y/y), net income $10.59B, EPS $11.71 |
| Feb 12, 20258-K | Other events |
| Feb 6, 20258-K | Results of operations |
| Jan 14, 20258-K | Results of operations |
2024 · 24 filings
| Filed | What it is |
|---|---|
| Nov 19, 20248-K | Directors or officers; compensation |
| Oct 30, 202410-Q | Quarterly report, Q3 2024 — revenue $11.44B (+20% y/y), net income $970.3M, EPS $1.07 |
| Oct 30, 20248-K | Results of operations |
| Sep 9, 20248-K | Directors or officers; compensation |
| Aug 16, 20248-K | Directors or officers; compensation |
| Aug 14, 20248-K | Other events |
| Aug 8, 202410-Q | Quarterly report, Q2 2024 — revenue $11.30B (+36% y/y), net income $2.97B, EPS $3.28 |
| Aug 8, 20248-K | Results of operations |
| Jul 10, 20248-K | Directors or officers; compensation |
| Jun 5, 20248-K | Directors or officers; compensation |
| May 9, 20248-K | Shareholder vote results |
| Apr 30, 202410-Q | Quarterly report, Q1 2024 — revenue $8.77B (+26% y/y), net income $2.24B, EPS $2.48 |
| Apr 30, 20248-K | Results of operations |
| Apr 11, 2024PX14A6G | Shareholder exempt solicitation |
| Apr 4, 2024PX14A6G | Shareholder exempt solicitation |
| Mar 28, 2024PX14A6G | Shareholder exempt solicitation |
| Mar 28, 2024PX14A6G | Shareholder exempt solicitation |
| Mar 28, 2024PX14A6G | Shareholder exempt solicitation |
| Mar 22, 2024DEFA14A | Additional proxy materials |
| Mar 22, 2024DEF 14A | Proxy statement |
| Mar 8, 2024PRE 14A | Preliminary proxy statement |
| Feb 21, 202410-K | Annual report, FY2023 — revenue $34.12B (+20% y/y), net income $5.24B, EPS $5.80 |
| Feb 9, 20248-K | Other events |
| Feb 6, 20248-K | Results of operations |
2023 · 19 filings — 7 × 8-K, 5 × PX14A6G, 3 × 10-Q and 4 other forms
| Filed | What it is |
|---|---|
| Nov 2, 202310-Q | Quarterly report, Q3 2023 — revenue $9.50B (+37% y/y), net income −$57.4M, EPS −$0.06 |
| Aug 8, 202310-Q | Quarterly report, Q2 2023 — revenue $8.31B (+28% y/y), net income $1.76B, EPS $1.95 |
| Apr 27, 202310-Q | Quarterly report, Q1 2023 — revenue $6.96B (−11% y/y), net income $1.34B, EPS $1.49 |
| Apr 21, 2023PX14A6G | Shareholder exempt solicitation |
| Apr 10, 2023PX14A6G | Shareholder exempt solicitation |
| Apr 4, 2023PX14A6G | Shareholder exempt solicitation |
| Mar 24, 2023PX14A6G | Shareholder exempt solicitation |
| Mar 22, 2023PX14A6G | Shareholder exempt solicitation |
| Mar 17, 2023DEFA14A | Additional proxy materials |
| Mar 17, 2023DEF 14A | Proxy statement |
| Feb 24, 2023PRE 14A | Preliminary proxy statement |
| Feb 22, 202310-K | Annual report, FY2022 — revenue $28.54B (+1% y/y), net income $6.24B, EPS $6.90 |
7 current reports (8-K) not listed; the year is on EDGAR.
2022 · 22 filings — 10 × 8-K, 5 × PX14A6G, 3 × 10-Q and 4 other forms
| Filed | What it is |
|---|---|
| Nov 1, 202210-Q | Quarterly report, Q3 2022 — revenue $6.94B (+2% y/y), net income $1.45B, EPS $1.61 |
| Aug 4, 202210-Q | Quarterly report, Q2 2022 — revenue $6.49B (−4% y/y), net income $952.5M, EPS $1.05 |
| Apr 29, 202210-Q | Quarterly report, Q1 2022 — revenue $7.81B (+15% y/y), net income $1.90B, EPS $2.10 |
| Apr 12, 2022PX14A6G | Shareholder exempt solicitation |
| Mar 31, 2022PX14A6G | Shareholder exempt solicitation |
| Mar 30, 2022PX14A6G | Shareholder exempt solicitation |
| Mar 22, 2022PX14A6G | Shareholder exempt solicitation |
| Mar 22, 2022PX14A6G | Shareholder exempt solicitation |
| Mar 18, 2022DEFA14A | Additional proxy materials |
| Mar 18, 2022DEF 14A | Proxy statement |
| Feb 25, 2022PRE 14A | Preliminary proxy statement |
| Feb 23, 202210-K | Annual report, FY2021 — revenue $28.32B (+15% y/y), net income $5.58B, EPS $6.12 |
10 current reports (8-K) not listed; the year is on EDGAR.
2021 · 25 filings — 14 × 8-K, 3 × 10-Q, 3 × PX14A6G and 4 other forms
| Filed | What it is |
|---|---|
| Oct 27, 202110-Q | Quarterly report, Q3 2021 — revenue $6.77B (+18% y/y), net income $1.11B, EPS $1.22 |
| Aug 3, 202110-Q | Quarterly report, Q2 2021 — revenue $6.74B (+23% y/y), net income $1.39B, EPS $1.53 |
| Apr 30, 202110-Q | Quarterly report, Q1 2021 — revenue $6.81B (+16% y/y), net income $1.36B, EPS $1.49 |
| Apr 20, 2021DEFA14A | Additional proxy materials |
| Mar 29, 2021PX14A6G | Shareholder exempt solicitation |
| Mar 29, 2021PX14A6G | Shareholder exempt solicitation |
| Mar 25, 2021PX14A6G | Shareholder exempt solicitation |
| Mar 19, 2021DEFA14A | Additional proxy materials |
| Mar 19, 2021DEF 14A | Proxy statement |
| Feb 18, 2021PRE 14A | Preliminary proxy statement |
| Feb 17, 202110-K | Annual report, FY2020 — revenue $24.54B (+10% y/y), net income $6.19B, EPS $6.79 |
14 current reports (8-K) not listed; the year is on EDGAR.
2020 · 22 filings — 8 × 8-K, 4 × DEFA14A, 4 × PX14A6G and 4 other forms
| Filed | What it is |
|---|---|
| Oct 28, 202010-Q | Quarterly report, Q3 2020 — revenue $5.74B (+5% y/y), net income $1.21B, EPS $1.33 |
| Jul 31, 202010-Q | Quarterly report, Q2 2020 — revenue $5.50B (−2% y/y), net income $1.41B, EPS $1.55 |
| May 1, 202010-Q | Quarterly report, Q1 2020 — revenue $5.86B (+15% y/y), net income $1.46B, EPS $1.60 |
| Apr 27, 2020PX14A6G | Shareholder exempt solicitation |
| Apr 15, 2020DEFA14A | Additional proxy materials |
| Apr 7, 2020DEFA14A | Additional proxy materials |
| Mar 24, 2020PX14A6G | Shareholder exempt solicitation |
| Mar 24, 2020PX14A6G | Shareholder exempt solicitation |
| Mar 23, 2020PX14A6G | Shareholder exempt solicitation |
| Mar 20, 2020DEFA14A | Additional proxy materials |
| Mar 20, 2020DEFA14A | Additional proxy materials |
| Mar 20, 2020DEF 14A | Proxy statement |
| Feb 20, 2020PRE 14A | Preliminary proxy statement |
| Feb 19, 202010-K | Annual report, FY2019 — revenue $22.32B (+4% y/y), net income $8.32B, EPS $8.89 |
8 current reports (8-K) not listed; the year is on EDGAR.
2019 · 24 filings — 14 × 8-K, 3 × 10-Q, 3 × DEFA14A and 4 other forms
| Filed | What it is |
|---|---|
| Oct 25, 201910-Q | Quarterly report, Q3 2019 — revenue $5.48B (+3% y/y), net income $1.25B, EPS $1.37 |
| Aug 2, 201910-Q | Quarterly report, Q2 2019 — revenue $5.64B (+1% y/y), net income $1.33B, EPS $1.44 |
| May 2, 201910-Q | Quarterly report, Q1 2019 — revenue $5.09B (+3% y/y), net income $4.24B, EPS $4.31 |
| Apr 22, 2019DEFA14A | Additional proxy materials |
| Apr 2, 2019PX14A6G | Shareholder exempt solicitation |
| Mar 22, 2019DEFA14A | Additional proxy materials |
| Mar 22, 2019DEFA14A | Additional proxy materials |
| Mar 22, 2019DEF 14A | Proxy statement |
| Feb 25, 2019PRE 14A | Preliminary proxy statement |
| Feb 19, 201910-K | Annual report, FY2018 — revenue $21.49B (+8% y/y), net income $3.23B, EPS $3.13 |
14 current reports (8-K) not listed; the year is on EDGAR.
2018 · 22 filings — 10 × 8-K, 3 × 10-Q, 3 × DEFA14A and 4 other forms
| Filed | What it is |
|---|---|
| Nov 6, 201810-Q | Quarterly report, Q3 2018 — revenue $5.31B (−6% y/y), net income $1.15B, EPS $1.12 |
| Jul 25, 201810-Q | Quarterly report, Q2 2018 — revenue $5.58B (−4% y/y), net income −$259.9M, EPS −$0.25 |
| Apr 27, 201810-Q | Quarterly report, Q1 2018 — revenue $4.96B (−5% y/y), net income $1.22B, EPS $1.16 |
| Apr 23, 2018DEFA14A | Additional proxy materials |
| Mar 28, 2018PX14A6G | Shareholder exempt solicitation |
| Mar 27, 2018PX14A6G | Shareholder exempt solicitation |
| Mar 19, 2018PX14A6G | Shareholder exempt solicitation |
| Mar 19, 2018DEFA14A | Additional proxy materials |
| Mar 19, 2018DEFA14A | Additional proxy materials |
| Mar 19, 2018DEF 14A | Proxy statement |
| Feb 23, 2018PRE 14A | Preliminary proxy statement |
| Feb 20, 201810-K | Annual report, FY2017 — revenue $19.97B (−6% y/y), net income −$204.1M, EPS −$0.19 |
10 current reports (8-K) not listed; the year is on EDGAR.
2017 · 18 filings — 10 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Oct 27, 201710-Q | Quarterly report, Q3 2017 — revenue $5.66B (+9% y/y), net income $555.6M, EPS $0.53 |
| Jul 28, 201710-Q | Quarterly report, Q2 2017 — revenue $5.82B (+8% y/y), net income $1.01B, EPS $0.95 |
| May 1, 201710-Q | Quarterly report, Q1 2017 — revenue $5.23B (+7% y/y), net income −$110.8M, EPS −$0.10 |
| Apr 24, 2017DEFA14A | Additional proxy materials |
| Mar 29, 2017DEFA14A | Additional proxy materials |
| Mar 20, 2017DEF 14A | Proxy statement |
| Feb 21, 201710-K | Annual report, FY2016 — revenue $21.22B (+6% y/y), net income $2.74B, EPS $2.58 |
11 current reports (8-K) not listed; the year is on EDGAR.
2016 · 15 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2015 · 15 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2014 · 15 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2013 · 19 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2012 · 18 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2011 · 15 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2010 · 14 filings — 5 × 8-K, 3 × 10-Q, 1 × 10-K and 5 other forms
Counted, not listed; the year is on EDGAR.
2009 · 23 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 6 other forms
Counted, not listed; the year is on EDGAR.
2008 · 22 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 7 other forms
Counted, not listed; the year is on EDGAR.
2007 · 16 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2006 · 13 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2005 · 17 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2004 · 14 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2003 · 11 filings — 5 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2002 · 10 filings — 3 × 10-Q, 3 × 8-K, 1 × 10-K405 and 3 other forms
Counted, not listed; the year is on EDGAR.
2001 · 6 filings — 3 × 10-Q, 1 × 10-K, 1 × 8-K and 1 other form
Counted, not listed; the year is on EDGAR.
2000 · 5 filings — 3 × 10-Q, 1 × 10-K, 1 × DEF 14A
Counted, not listed; the year is on EDGAR.
1999 · 7 filings — 3 × 10-Q, 1 × 10-K, 1 × 10-Q/A and 2 other forms
Counted, not listed; the year is on EDGAR.
1998 · 7 filings — 3 × 10-Q, 1 × 10-K, 1 × 8-K and 2 other forms
Counted, not listed; the year is on EDGAR.
1997 · 5 filings — 3 × 10-Q, 1 × 10-K405, 1 × DEF 14A
Counted, not listed; the year is on EDGAR.
1996 · 7 filings — 3 × 10-Q, 1 × 10-K, 1 × 8-K and 2 other forms
Counted, not listed; the year is on EDGAR.
1995 · 10 filings — 5 × 8-K, 3 × 10-Q, 1 × 10-K405 and 1 other form
Counted, not listed; the year is on EDGAR.
1994 · 8 filings — 3 × 10-Q, 2 × 8-K, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 104 filings — 74 × 4, 10 × 144, 5 × SCHEDULE 13G/A and 10 other forms
| Filed | What it is |
|---|---|
| Sep 22, 20264 | Insider transaction (Form 4) |
| Sep 22, 20264 | Insider transaction (Form 4) |
| Sep 22, 20264 | Insider transaction (Form 4) |
| Sep 22, 20264 | Insider transaction (Form 4) |
| Sep 11, 20264 | Insider transaction (Form 4) |
| Sep 4, 20263/A | Initial insider holdings (Form 3), amended |
| Sep 4, 20264 | Insider transaction (Form 4) |
| Sep 4, 20264 | Insider transaction (Form 4) |
| Aug 18, 20264 | Insider transaction (Form 4) |
| Aug 18, 20264 | Insider transaction (Form 4) |
| Aug 18, 20264 | Insider transaction (Form 4) |
| Aug 18, 20264 | Insider transaction (Form 4) |
| Aug 18, 20264 | Insider transaction (Form 4) |
| Aug 17, 2026144 | Notice of proposed sale (Form 144) |
| Aug 11, 20264 | Insider transaction (Form 4) |
| Aug 10, 2026144 | Notice of proposed sale (Form 144) |
| Aug 10, 20264 | Insider transaction (Form 4) |
| Aug 7, 2026144 | Notice of proposed sale (Form 144) |
| Aug 3, 20264 | Insider transaction (Form 4) |
| Jul 30, 2026SCHEDULE 13D | Other filings |
| Jul 24, 2026SCHEDULE 13G/A | Other filings |
| Jul 24, 2026SCHEDULE 13G | Other filings |
| Jul 23, 20263 | Initial insider holdings (Form 3) |
| Jul 23, 2026SCHEDULE 13G/A | Other filings |
| Jul 21, 20264 | Insider transaction (Form 4) |
The newest 25 of 104 shown; the full year is on EDGAR.
2025 · 199 filings — 151 × 4, 22 × 144, 5 × SCHEDULE 13G/A and 10 other forms
| Filed | What it is |
|---|---|
| Dec 30, 20254 | Insider transaction (Form 4) |
| Dec 29, 20254 | Insider transaction (Form 4) |
| Dec 29, 20254 | Insider transaction (Form 4) |
| Dec 23, 2025144 | Notice of proposed sale (Form 144) |
| Dec 16, 20254 | Insider transaction (Form 4) |
| Dec 16, 20254 | Insider transaction (Form 4) |
| Dec 16, 20254 | Insider transaction (Form 4) |
| Dec 16, 20254 | Insider transaction (Form 4) |
| Dec 16, 20254 | Insider transaction (Form 4) |
| Dec 9, 2025SC TO-T/A | Beneficial ownership |
| Dec 8, 20253 | Initial insider holdings (Form 3) |
| Nov 26, 20254 | Insider transaction (Form 4) |
| Nov 26, 20254 | Insider transaction (Form 4) |
| Nov 25, 20254 | Insider transaction (Form 4) |
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 24, 2025144 | Notice of proposed sale (Form 144) |
| Nov 21, 20254 | Insider transaction (Form 4) |
| Nov 20, 20254 | Insider transaction (Form 4) |
| Nov 19, 20254 | Insider transaction (Form 4) |
| Nov 19, 2025144 | Notice of proposed sale (Form 144) |
| Nov 18, 20254 | Insider transaction (Form 4) |
| Nov 18, 20254 | Insider transaction (Form 4) |
| Nov 18, 20254 | Insider transaction (Form 4) |
| Nov 18, 20254 | Insider transaction (Form 4) |
| Nov 18, 20254 | Insider transaction (Form 4) |
The newest 25 of 199 shown; the full year is on EDGAR.
2024 · 180 filings — 140 × 4, 19 × 144, 4 × 3 and 8 other forms
| Filed | What it is |
|---|---|
| Dec 17, 20244 | Insider transaction (Form 4) |
| Dec 17, 20244 | Insider transaction (Form 4) |
| Dec 17, 20244 | Insider transaction (Form 4) |
| Dec 17, 20244 | Insider transaction (Form 4) |
| Dec 17, 20244 | Insider transaction (Form 4) |
| Dec 4, 20243 | Initial insider holdings (Form 3) |
| Nov 20, 20244 | Insider transaction (Form 4) |
| Nov 20, 20244 | Insider transaction (Form 4) |
| Nov 20, 20244 | Insider transaction (Form 4) |
| Nov 20, 20244 | Insider transaction (Form 4) |
| Nov 20, 20244 | Insider transaction (Form 4) |
| Nov 20, 20244 | Insider transaction (Form 4) |
| Nov 20, 20244 | Insider transaction (Form 4) |
| Nov 20, 20244 | Insider transaction (Form 4) |
| Nov 20, 20244 | Insider transaction (Form 4) |
| Nov 20, 20244 | Insider transaction (Form 4) |
| Nov 8, 2024144 | Notice of proposed sale (Form 144) |
| Nov 8, 20244 | Insider transaction (Form 4) |
| Nov 5, 20244 | Insider transaction (Form 4) |
| Nov 5, 20244 | Insider transaction (Form 4) |
| Nov 5, 20244 | Insider transaction (Form 4) |
| Nov 1, 20244 | Insider transaction (Form 4) |
| Oct 23, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Oct 22, 20244 | Insider transaction (Form 4) |
| Oct 22, 20244 | Insider transaction (Form 4) |
The newest 25 of 180 shown; the full year is on EDGAR.
2023 · 220 filings — 160 × 4, 17 × 144, 13 × SC TO-T/A and 14 other forms
Counted, not listed; the year is on EDGAR.
2022 · 186 filings — 158 × 4, 9 × SC 13G/A, 3 × SC TO-T/A and 13 other forms
Counted, not listed; the year is on EDGAR.
2021 · 141 filings — 106 × 4, 7 × 3, 6 × SC 13G and 13 other forms
Counted, not listed; the year is on EDGAR.
2020 · 117 filings — 87 × 4, 7 × 3, 3 × SC 13G/A and 12 other forms
Counted, not listed; the year is on EDGAR.
2019 · 223 filings — 133 × 4, 35 × 425, 15 × 4/A and 19 other forms
Counted, not listed; the year is on EDGAR.
2018 · 180 filings — 143 × 4, 10 × SC 13G/A, 7 × 3 and 10 other forms
Counted, not listed; the year is on EDGAR.
2017 · 133 filings — 96 × 4, 7 × 5, 6 × 3 and 14 other forms
Counted, not listed; the year is on EDGAR.
2016 · 125 filings — 95 × 4, 7 × 5, 4 × CORRESP and 11 other forms
Counted, not listed; the year is on EDGAR.
2015 · 113 filings — 85 × 4, 6 × SC 13G/A, 4 × 5 and 13 other forms
Counted, not listed; the year is on EDGAR.
2014 · 128 filings — 99 × 4, 4 × 4/A, 4 × 5 and 11 other forms
Counted, not listed; the year is on EDGAR.
2013 · 82 filings — 65 × 4, 4 × 3, 4 × 5 and 7 other forms
Counted, not listed; the year is on EDGAR.
2012 · 79 filings — 55 × 4, 5 × 5, 4 × 3 and 6 other forms
Counted, not listed; the year is on EDGAR.
2011 · 95 filings — 65 × 4, 6 × 5, 6 × CORRESP and 6 other forms
Counted, not listed; the year is on EDGAR.
2010 · 78 filings — 45 × 4, 11 × CORRESP, 7 × 5 and 7 other forms
Counted, not listed; the year is on EDGAR.
2009 · 76 filings — 48 × 4, 7 × 3, 5 × 5 and 8 other forms
Counted, not listed; the year is on EDGAR.
2008 · 147 filings — 110 × 4, 7 × SC TO-T/A, 5 × 5 and 10 other forms
Counted, not listed; the year is on EDGAR.
2007 · 131 filings — 109 × 4, 6 × 5, 3 × CORRESP and 7 other forms
Counted, not listed; the year is on EDGAR.
2006 · 212 filings — 200 × 4, 5 × 5, 3 × SC 13G/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2005 · 153 filings — 137 × 4, 5 × 3, 5 × 5 and 3 other forms
Counted, not listed; the year is on EDGAR.
2004 · 153 filings — 135 × 4, 6 × 5, 4 × 3 and 5 other forms
Counted, not listed; the year is on EDGAR.
2003 · 89 filings — 75 × 4, 2 × 3, 2 × SC 13G/A and 10 other forms
Counted, not listed; the year is on EDGAR.
2002 · 5 filings — 3 × SC 13G/A, 1 × 424B5, 1 × NO ACT
Counted, not listed; the year is on EDGAR.
2001 · 7 filings — 3 × SC 13G/A, 2 × SC 13G, 1 × 424B5 and 1 other form
Counted, not listed; the year is on EDGAR.
2000 · 6 filings — 3 × SC 13G/A, 2 × SC 13G, 1 × S-3
Counted, not listed; the year is on EDGAR.
1999 · 3 filings — 1 × S-8, 1 × SC 13G, 1 × SC 13G/A
Counted, not listed; the year is on EDGAR.
1998 · 8 filings — 4 × SC 13D/A, 2 × S-8, 1 × 8-A12B and 1 other form
Counted, not listed; the year is on EDGAR.
1997 · 5 filings — 3 × SC 13G, 2 × SC 13D
Counted, not listed; the year is on EDGAR.
1996 · 4 filings — 1 × 424B2, 1 × 8-A12B, 1 × S-8 and 1 other form
Counted, not listed; the year is on EDGAR.
1995 · 16 filings — 3 × 424B3, 3 × SC 13E4/A, 2 × 424B2 and 7 other forms
Counted, not listed; the year is on EDGAR.
1994 · 19 filings — 13 × SC 14D1/A, 2 × 424B2, 1 × S-8 and 3 other forms
Counted, not listed; the year is on EDGAR.
About this data
Eli Lilly and Company (LLY) has 3,915 filings on EDGAR going back to 1994: 34 annual reports, 101 quarterly reports and 242 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 12, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Aug 5, 2026, covered results of operations. Over the last 13 months insiders sold $358.5M in 7 sales and bought nothing on the open market; 97 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been Eli Lilly and Company, read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read LLY's latest 10-K?
- LLY's latest annual report, a 10-K, was filed on Feb 12, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did LLY last file an 8-K?
- On Aug 5, 2026: results of operations. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 5, 2026.
- Are LLY insiders buying or selling?
- Over the last 13 months insiders sold $358.5M in 7 sales and bought nothing on the open market; 97 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Jonsson Patrik (EVP & President, LLY Int'l) sold 6,500 shares on Aug 17, 2026 for $7.6M, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has LLY made?
- 3,915 filings are on EDGAR under the registrant records that have been Eli Lilly and Company, going back to 1994; 2,875 of them are insider ownership forms (Forms 3, 4, 5 and 144).
